NASDAQ : RDGT
Ridgetech, Inc. — Key statistics
Healthcare · Pharmaceutical Retailers · China
Last price 0.8029 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 2.91M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 2.94M |
| Enterprise Value | -14.94M |
Dates
| Measure | Value |
|---|
| Earnings Date | Jul 31, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 3.63M |
| Shares Outstanding | 3.63M |
| Shares Change (YoY) | +96.64% |
| Shares Change (QoQ) | +172.33% |
| Owned by Insiders (%) | 0.41% |
| Owned by Institutions (%) | 3.79% |
| Float | 3.61M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.02 |
| Forward PS | n/a |
| PB Ratio | 0.02 |
| P/TBV Ratio | 0.09 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.31 |
| Quick Ratio | 1.99 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -27.82 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -3.55% |
| Return on Assets (ROA) | -1.75% |
| Return on Invested Capital (ROIC) | -8.15% |
| Return on Capital Employed (ROCE) | -4.54% |
| Weighted Average Cost of Capital (WACC) | 4.74% |
| Revenue Per Employee | $2.07M |
| Profits Per Employee | -$19,538 |
| Employee Count | 64 |
| Asset Turnover | 1.98 |
| Inventory Turnover | 13.74 |
Taxes
| Measure | Value |
|---|
| Income Tax | -99,098 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | -0.21 |
| 52-Week Price Change | -99.67% |
| 50-Day Moving Average | 0.88 |
| 200-Day Moving Average | 67.49 |
| Relative Strength Index (RSI) | 44.74 |
| Average Volume (20 Days) | 43,691 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 167,156 |
| Short Previous Month | 259,247 |
| Short % of Shares Out | 4.61% |
| Short % of Float | 4.62% |
| Short Ratio (days to cover) | 0.36 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 132.16M |
| Gross Profit | 4.75M |
| Operating Income | -1.87M |
| Pretax Income | -1.35M |
| Net Income | -1.25M |
| EBITDA | -1.50M |
| EBIT | -1.87M |
| Loss Per Share | -$17.21 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 17.91M |
| Total Debt | 22,669 |
| Net Cash | 17.88M |
| Net Cash Per Share | $4.93 |
| Equity (Book Value) | 40.78M |
| Book Value Per Share | 45.96 |
| Working Capital | 36.66M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -1.39M |
| Capital Expenditures | -449 |
| Depreciation & Amortization | 363,686 |
| Net Borrowing | -10.59M |
| Free Cash Flow | -1.39M |
| FCF Per Share | -$0.38 |
Margins
| Measure | Value |
|---|
| Gross Margin | 3.60% |
| Operating Margin | -1.41% |
| Pretax Margin | -1.02% |
| Profit Margin | -0.95% |
| EBITDA Margin | -1.14% |
| EBIT Margin | -1.41% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -96.64% |
| Shareholder Yield | -96.64% |
| Earnings Yield | -2,124.69% |
| FCF Yield | -44.42% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Apr 8, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:150 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 1.55 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |